Key Benefits of Retatrutide:

​

• Significant Weight Loss: Clinical trials have shown that over 80% of participants lost at least 15% of their body weight, with some losing over 30%. It has shown superior weight loss results compared to current options like semaglutide and tirzepatide.

• Improved Metabolic Health: In addition to weight loss, the drug effectively lowers HbA1c levels by two percentage points or more in patients with type 2 diabetes

• Targeted Hormone Action: By acting as a triple agonist (GLP-1, GIP, and glucagon), it not only reduces appetite and slows digestion but also increases fat and energy burn.

• Potential Cardiovascular/Liver Benefits: Early studies suggest it may help improve heart health risk factors and reduce liver fat (steatosis).

• Long-lasting Effects: In studies, weight loss did not appear to plateau by the end of the 48-week, Phase 2 trial, suggesting potential for further weight loss with continued treatment. 

  ​